Management of a patient with factor X deficiency with FEIBA: a case report

1. Peyvandi F, Mannucci PM, Lak M, et al. Congenital factor X deficiency: spectrum of bleeding symptoms in 32 Iranian patients. Br J Haematol 1998; 102: 626-628. doi: 10.1046/j.1365-2141.1998.00806.x. Peyvandi F Mannucci PM Lak M . Congenital factor X deficiency: spectrum of bleeding symptoms in 32 Iranian patients . Br J Haematol 1998 ; 102 : 626 - 628 . doi: 10.1046/j.1365-2141.1998.00806.x . Open DOISearch in Google Scholar

2. Palla R, Peyvandi F, Shapiro AD. Rare bleeding disorders: diagnosis and treatment. Blood 2015; 125: 2052-2061. doi: 10.1182/blood-2014-08-532820. Palla R Peyvandi F Shapiro AD . Rare bleeding disorders: diagnosis and treatment . Blood 2015 ; 125 : 2052 - 2061 . doi: 10.1182/blood-2014-08-532820 . Open DOISearch in Google Scholar

3. Al-Mouqdad M, Abdelrahim A, Kahlon BMM, Almahmoud L, Asfour S. A successful treatment of infant who had two significant intracranial hemorrhage with factor X replacement: case report. Neonat Pediatr Med 2018; 4: 163. doi: 10.4172/2572-4983.1000163. Al-Mouqdad M Abdelrahim A Kahlon BMM Almahmoud L Asfour S . A successful treatment of infant who had two significant intracranial hemorrhage with factor X replacement: case report . Neonat Pediatr Med 2018 ; 4 : 163 . doi: 10.4172/2572-4983.1000163 . Open DOISearch in Google Scholar

4. Escobar MA. Advances in the treatment of inherited coagulation disorders. Haemophilia 2013; 19: 648-659. doi: 10.1111/hae.12137. Escobar MA . Advances in the treatment of inherited coagulation disorders . Haemophilia 2013 ; 19 : 648 - 659 . doi: 10.1111/hae.12137 . Open DOISearch in Google Scholar

5. Menegatti M, Peyvandi F. Factor X deficiency. Semin Thromb Hemost 2009; 35: 407-415. doi: 10.1055/s-0029-1225763. Menegatti M Peyvandi F . Factor X deficiency . Semin Thromb Hemost 2009 ; 35 : 407 - 415 . doi: 10.1055/s-0029-1225763 . Open DOISearch in Google Scholar

6. Powell JS, Rodgers GM. Inherited coagulation disorders. In: Greer JP, Arber DA, Glader B, et al. (eds.). Wintrobe’s Clinical Hematology. 13th edn. 2014. Philadelphia: Lippincott Williams & Wilkins.1143-1185. Powell JS Rodgers GM . Inherited coagulation disorders . In: Greer JP Arber DA Glader B . (eds.). Wintrobe’s Clinical Hematology . 13th edn . 2014 . Philadelphia : Lippincott Williams & Wilkins . 1143 - 1185 . Search in Google Scholar

7. World Federation of Hemophilia. Report on the Annual Global Survey 2021. October 2022. Available from https://www1.wfh.org/publications/files/pdf-2324.pdf (accessed 10 June 2023). World Federation of Hemophilia . Report on the Annual Global Survey 2021 . October 2022 . Available from https://www1.wfh.org/publications/files/pdf-2324.pdf ( accessed 10 June 2023 ). Search in Google Scholar

8. Shah NM, Patel AP. An analysis of 8 cases of factor X deficiency. Indian J Hematol Blood Transfus 2008; 24 (1): 23-25. doi: 10.1007/s12288-008-0018-7. Shah NM Patel AP . An analysis of 8 cases of factor X deficiency . Indian J Hematol Blood Transfus 2008 ; 24 ( 1 ): 23 - 25 . doi: 10.1007/s12288-008-0018-7 . Open DOISearch in Google Scholar

9. Sinha S, Barik S. Factor X deficiency: a rare case of inherited coagulation disorder presenting as hemarthrosis. Int J Med Res Rev 2014; 2(3): 253-255. doi:10.17511/ijmrr.2014.i03.14. Sinha S Barik S . Factor X deficiency: a rare case of inherited coagulation disorder presenting as hemarthrosis . Int J Med Res Rev 2014 ; 2 ( 3 ): 253 - 255 . doi: 10.17511/ijmrr.2014.i03.14 . Open DOISearch in Google Scholar

10. Chatterjee T, Philip J, Nair V, et al. Inherited factor X (Stuart-Prower factor) deficiency and its management. Med J Armed Forces India 2015; 71 (suppl 1): S184-S186. doi: 10.1016/j. mjafi.2014.01.007. Chatterjee T Philip J Nair V . Inherited factor X (Stuart-Prower factor) deficiency and its management . Med J Armed Forces India 2015 ; 71 (suppl 1): S184 - S186 . doi: 10.1016/j. mjafi.2014.01.007 . Open DOISearch in Google Scholar

11. Peyvandi F, Auerswald G, Austin SK, et al. Diagnosis, therapeutic advances, and key recommendations for the management of factor X deficiency. Blood Rev 2021; 50: 100833. doi: 10.1016/j.blre.2021.100833. Peyvandi F Auerswald G Austin SK . Diagnosis, therapeutic advances, and key recommendations for the management of factor X deficiency . Blood Rev 2021 ; 50 : 100833 . doi: 10.1016/j.blre.2021.100833 . Open DOISearch in Google Scholar

12. Mumford AD, Ackroyd S, Alikhan R, et al. Guideline for the diagnosis and management of the rare coagulation disorders: a United Kingdom Haemophilia Centre Doctors’ Organization guideline on behalf of the British Committee for Standards in Haematology. Br J Haematol 2014; 167: 304-26. doi: 10.1111/bjh.13058. Mumford AD Ackroyd S Alikhan R . Guideline for the diagnosis and management of the rare coagulation disorders: a United Kingdom Haemophilia Centre Doctors’ Organization guideline on behalf of the British Committee for Standards in Haematology . Br J Haematol 2014 ; 167 : 304 - 26 . doi: 10.1111/bjh.13058 . Open DOISearch in Google Scholar

13. Turecek PL, Váradi K, Gritsch H, Schwarz HP. FEIBA: mode of action. Haemophilia 2004; 10 Suppl 2: 3-9. doi: 10.1111/j.1365-2516.2004.00934.x. Turecek PL Váradi K Gritsch H Schwarz HP . FEIBA: mode of action . Haemophilia 2004 ; 10 Suppl 2: 3 - 9 . doi: 10.1111/j.1365-2516.2004.00934.x . Open DOISearch in Google Scholar

14. Bolton-Maggs PH, Perry DJ, Chalmers EA, et al. The rare coagulation disorders—review with guidelines for management from the United Kingdom Haemophilia Centre Doctors’ Organisation. Haemophilia 2004; 10: 593-628. doi: 10.1111/j.1365-2516.2004.00944.x. Bolton-Maggs PH Perry DJ Chalmers EA . The rare coagulation disorders—review with guidelines for management from the United Kingdom Haemophilia Centre Doctors’ Organisation . Haemophilia 2004 ; 10 : 593 - 628 . doi: 10.1111/j.1365-2516.2004.00944.x . Open DOISearch in Google Scholar

15. Peyvandi F, Palla R, Menegatti M, et al. Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding Disorders. J Thromb Haemost 2012; 10: 615-21. doi: 10.1111/j.1538-7836.2012.04653.x. Peyvandi F Palla R Menegatti M . Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding Disorders . J Thromb Haemost 2012 ; 10 : 615 - 21 . doi: 10.1111/j.1538-7836.2012.04653.x . Open DOISearch in Google Scholar

16. Peyvandi F, Di Michele D, Bolton-Maggs PH, et al. Classification of rare bleeding disorders (RBDs) based on the association between coagulant factor activity and clinical bleeding severity. J Thromb Haemost 2012; 10: 1938-43. doi: 10.1111/j.1538-7836.2012.04844.x. Peyvandi F Di Michele D Bolton-Maggs PH . Classification of rare bleeding disorders (RBDs) based on the association between coagulant factor activity and clinical bleeding severity . J Thromb Haemost 2012 ; 10 : 1938 - 43 . doi: 10.1111/j.1538-7836.2012.04844.x . Open DOISearch in Google Scholar

17. Shinohara K, Adachi M, Matsui K, et al. A case of factor X (FX) deficiency due to novel mutation V196M, FX Hofu. Int J Hematol 2008; 87(3): 256-259. doi: 10.1007/s12185-008-0035-1. Shinohara K Adachi M Matsui K . A case of factor X (FX) deficiency due to novel mutation V196M, FX Hofu . Int J Hematol 2008 ; 87 ( 3 ): 256 - 259 . doi: 10.1007/s12185-008-0035-1 . Open DOISearch in Google Scholar

18. Peyvandi F, Menegatti M, Santagostino E, et al. Gene mutations and three-dimensional structural analysis in 13 families with severe factor X deficiency. Br J Haematol 2002; 117: 685-692. doi: 10.1046/j.1365-2141.2002.03486.x. Peyvandi F Menegatti M Santagostino E . Gene mutations and three-dimensional structural analysis in 13 families with severe factor X deficiency . Br J Haematol 2002 ; 117 : 685 - 692 . doi: 10.1046/j.1365-2141.2002.03486.x . Open DOISearch in Google Scholar

19. Telfer TP, Denson KW, Wright DR. A ‘new’ coagulation defect. Br J Haematol 1956; 2(3): 308-316. doi: 10.1111/j.1365-2141-1956.tb06703.x. Telfer TP Denson KW Wright DR . A ‘new’ coagulation defect . Br J Haematol 1956 ; 2 ( 3 ): 308 - 316 . doi: 10.1111/j.1365-2141-1956.tb06703.x . Open DOISearch in Google Scholar

20. Hougie C, Barrow EM, Graham JB. Stuart clotting defect. I. Segregation of an hereditary hemorrhagic state from the heterogeneous group heretofore called stable factor (SPCA, proconvertin, factor VII) deficiency. J Clin Invest 1957; 36: 485-496. doi: 10.1172/JCI103446. Hougie C Barrow EM Graham JB . Stuart clotting defect. I. Segregation of an hereditary hemorrhagic state from the heterogeneous group heretofore called stable factor (SPCA, proconvertin, factor VII) deficiency . J Clin Invest 1957 ; 36 : 485 - 496 . doi: 10.1172/JCI103446 . Open DOISearch in Google Scholar

21. Redely SV, Zhou ZQ, Rao KJ, Scott JP, Watzke H, High KA, Jagadeeswaran P. Molecular characterization of human factor XSan.Antonio. Blood 1989; 74(5): 1486-90. doi: 10.1182/blood. V74.5.1486.1486. Redely SV Zhou ZQ Rao KJ Scott JP Watzke H High KA Jagadeeswaran P . Molecular characterization of human factor XSan.Antonio . Blood 1989 ; 74 ( 5 ): 1486 - 90 . doi: 10.1182/blood. V74.5.1486.1486 . Open DOISearch in Google Scholar

22. James HL, Girolami A, Fair DS. Molecular defect in coagulation factor XFriuli results from a substitution of serine for proline at position 343. Blood 1991; 77: 317-323. doi: 10.1182/blood.V77.2.317.317. James HL Girolami A Fair DS . Molecular defect in coagulation factor XFriuli results from a substitution of serine for proline at position 343 . Blood 1991 ; 77 : 317 - 323 . doi: 10.1182/blood.V77.2.317.317 . Open DOISearch in Google Scholar

23. Ermis B, Ors R, Tastekin A, Orhan F. Severe congenital factor X deficiency with intracranial bleeding in two siblings. Brain Dev 2004; 6: 137-138. doi: 10.1016/S0387-7604(03)00119-0. Ermis B Ors R Tastekin A Orhan F . Severe congenital factor X deficiency with intracranial bleeding in two siblings . Brain Dev 2004 ; 6 : 137 - 138 . doi: 10.1016/S0387-7604(03)00119-0 . Open DOISearch in Google Scholar

24. Sandler E, Gross S. Prevention of recurrent intracranial hemorrhage in a factor X-deficient infant. Am J Pediatr Hematol Oncol 1992; 14: 163-165. doi: 10.1097/00043426-199205000-00012. Sandler E Gross S . Prevention of recurrent intracranial hemorrhage in a factor X-deficient infant . Am J Pediatr Hematol Oncol 1992 ; 14 : 163 - 165 . doi: 10.1097/00043426-199205000-00012 . Open DOISearch in Google Scholar

25. el Kalla S, Menon NS. Neonatal congenital factor X deficiency. Pediatr Hematol Oncol 1991; 8: 347-354. doi: 10.3109/08880019109028808. el Kalla S Menon NS . Neonatal congenital factor X deficiency . Pediatr Hematol Oncol 1991 ; 8 : 347 - 354 . doi: 10.3109/08880019109028808 . Open DOISearch in Google Scholar

26. Shim YJ, Won DI. Pharmacokinetics and prophylactic use of FEIBA ® in a child with severe congenital factor X deficiency and recurrent spontaneous intracranial haemorrhage: a case report. Haemophilia 2013; 19(6): e364–7. doi: 10.1111/hae.12245. Shim YJ Won DI . Pharmacokinetics and prophylactic use of FEIBA ® in a child with severe congenital factor X deficiency and recurrent spontaneous intracranial haemorrhage: a case report . Haemophilia 2013 ; 19 ( 6 ): e364–7 . doi: 10.1111/hae.12245 . Open DOISearch in Google Scholar